Potential CYP2C9-mediated drug-drug interactions in hospitalized type 2 diabetes mellitus patients treated with the sulphonylureas glibenclamide, glimepiride or glipizide.

Tirkkonen, T

Potential CYP2C9-mediated drug-drug interactions in hospitalized type 2 diabetes mellitus patients treated with the sulphonylureas glibenclamide, glimepiride or glipizide. [electronic resource] - Journal of internal medicine Oct 2010 - 359-66 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1365-2796

10.1111/j.1365-2796.2010.02257.x doi


Adolescent
Adult
Aged
Aged, 80 and over
Aryl Hydrocarbon Hydroxylases--antagonists & inhibitors
Cytochrome P-450 CYP2C9
Diabetes Mellitus, Type 2--drug therapy
Drug Interactions
Female
Glipizide--therapeutic use
Glyburide--therapeutic use
Hospitalization
Humans
Hypoglycemic Agents--therapeutic use
Male
Middle Aged
Sulfonylurea Compounds--therapeutic use
Young Adult